SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-057514
Filing Date
2017-11-09
Accepted
2017-11-09 09:53:08
Documents
47
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv477959_10q.htm 10-Q 281857
2 EXHIBIT 31.1 tv477959_ex31-1.htm EX-31.1 10208
3 EXHIBIT 32.1 tv477959_ex32-1.htm EX-32.1 4459
  Complete submission text file 0001144204-17-057514.txt   2660472

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ttnp-20170930.xml EX-101.INS 601296
5 XBRL TAXONOMY EXTENSION SCHEMA ttnp-20170930.xsd EX-101.SCH 27244
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttnp-20170930_cal.xml EX-101.CAL 23857
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttnp-20170930_def.xml EX-101.DEF 173844
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttnp-20170930_lab.xml EX-101.LAB 208224
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttnp-20170930_pre.xml EX-101.PRE 198518
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13341 | Film No.: 171188615
SIC: 2836 Biological Products, (No Diagnostic Substances)